Wyeth, Impax Settle Effexor Patent Dispute
Judge Joseph J. Farnan, Jr. of the U.S. District Court for the District of Delaware entered a consent judgment on Tuesday, approving the June 9 settlement. The companies announced the deal Wednesday.
Under the terms of the settlement, Wyeth has licensed Impax to launch its generic version of the drug on or after June 1, 2011. Certain circumstances may allow the generics maker to sell the drug earlier,...
To view the full article, register now.